Anandamide (AEA) is an agonist of the cannabinoid and non-cannabinoid receptors. It is an N-acyl ethanolamide derivative of C20:4 fatty acid, which is also known as arachidonic acid. AEA is a lipid neurotransmitter synthesized and released by the brain nerve cells as well as macrophages.
Anandamide (AEA) is involved in many physiological and pathophysiological functions, such as regulation of energy consumption and balance. It is also involved in initiation and control of inflammation and modulatory effects on sensory and autonomic nerve signaling.
